Biocodex operates three manufacturing facilities in France and Morocco in compliance with the highest standards to guarantee product quality and safety.
Biocodex’s state-of-the-art manufacturing and logistics center in Beauvais, France
Biocodex has operated a 9-hectare manufacturing and logistics center in Beauvais, near Paris, since 1968.
Initially focused on manufacturing Biocodex’s Saccharomyces boulardii CNCM I-745® probiotic yeast, the plant has been progressively upgraded to meet growing demand as the company has expanded. Since 2005, Biocodex has accelerated this process, investing in state-of-the-art equipment and technologies. In 2017, Biocodex reached an important milestone with the installation of one of the pharmaceutical industry’s largest lyophilization platforms worldwide, for Saccharomyces boulardii CNCM I-745®. This extension was a real technical feat as it was held without interrupting a single day production.
This platform houses around
- 30 pieces of equipment,
- Two 15,000-liter bioreactors,
- One centrifugal separator and
- Two 55 m² freeze dryers.
Biocodex industrial facility
Learn more with this 2:44 minutes video about Biocodex’s plant certified Good Manufacturing Practices (GMP) guaranteeing the best product quality worldwide.
Biocodex’s Good Manufacturing Practices Certifications
The Beauvais factory controls the entire drug production process from manufacturing to shipping. Depending on the product, our facility may produce the active pharmaceutical ingredient and/or package the final product. In all cases, Beauvais is at the heart of our quality system, complying with Good Manufacturing Practices (GMP) as certified by France’s National Agency for the Safety of Medicines and Health Products (ANSM), the United States Food and Drug Administration (USFDA) and other national authorities worldwide.
Beauvais Key figures
- More than 200 employees
- 6,000 m2 logistics hub
- 90 million boxes shipped every year
- 96% on-time delivery
- Shipping to more than 120 countries
Biocodex plant in Casablanca, Morocco
Biocodex has operated a 1-hectare plant in Nouaceur, near Casablanca, since 2012. This facility focuses on manufacturing Biocodex products in liquid form.
The Casablanca factory controls the entire drug production process from manufacturing to distribution and quality control, complying with Moroccan and European Good Manufacturing Practices (GMP).
Casablanca plant key figures
- 40 million vials per year
- 2 production lines
- 50 highly qualified operators
Ferlux plant, France
Acquired by Biocodex in 2014, Ferlux operates a 2-hectare plant near Clermont-Ferrand in the South of France. As a pioneer in the science of polyphenols and the producer of the only bilberry extract with active pharmaceutical ingredient status, Ferlux is passionate about the diversity of colorful flavonoids and their extraordinary health benefits.
Using biotechnologies and soft extraction/purification processes, Ferlux produces premium-quality bioflavonoid-rich dry extracts from carefully selected superfruits.
Want to know more?
Investing in start-ups
Biocodex has invested in start-ups since 2016 and become a key player in the French biotech ecosystem. We focus mainly on companies developing medical unmet needs and innovative therapeutics from probiotics, or microbial strains that are beneficial to health. With its long-term approach and industrial expertise, Biocodex is recognized as a valuable partner by CEOs, project owners and traditional investors, such as fund managers. Biocodex is always looking to support new meaningful projects.